Adenosine plasma level and A 2A adenosine receptor expression: Correlation with laboratory tests in patients with neurally mediated syncope

Heart

Volumn 98, Issue 11, 2012, Pages 855-859

  Deharo, Jean Claude ^a,b   Mechulan, Alexis ^a   Giorgi, Roch ^b   Franceschi, Frederic ^a   Prevot, Sebastien ^a   Peyrouse, Eric ^a   Condo, Jocelyne ^b   By, Youlet ^b   Ruf, Jean ^b   Brignole, Michelino ^c   Guieu, Régis ^a,b  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Ospedale di Lavagna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

A2A ADENOSINE RECEPTOR; ADENOSINE; ADENOSINE A2 RECEPTOR; ADENOSINE TRIPHOSPHATE; UNCLASSIFIED DRUG;

ADENOSINE BLOOD LEVEL; ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD TILTING; HUMAN; HUMAN CELL; LABORATORY TEST; MALE; NEURALLY MEDIATED SYNCOPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SYNCOPE;

ADENOSINE; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; HUMANS; MEN; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECEPTOR, ADENOSINE A2A; SENSITIVITY AND SPECIFICITY; SYNCOPE, VASOVAGAL; TILT-TABLE TEST; WOMEN;

EID: 84862070674     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-301411     Document Type: Article

References (24)

1. Sutton R, Bloomfield DM. Indications, methodology, and classification of results of tilt table testing. Am J Cardiol 1999;84:10-19.
2. Moya A, Sutton R, Ammirati F, et al; Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS). Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-71.
3. Shen WK, Hammill SC, Munger TM, et al. Adenosine: potential modulator for vasovagal syncope. J Am Coll Cardiol 1996;28:146-54. (Pubitemid 26266634)
4. Mittal S, Stein KM, Markowitz SM, et al. Induction of neurally mediated syncope with adenosine. Circulation 1999;99:1318-24. (Pubitemid 29129916)
5. Flammang D, Erickson M, McCarville S, et al. Contribution of head-up tilt test and ATP testing in assessing the mechanisms of vasovagal syndrome: preliminary results and potential therapeutic implications. Circulation 1999;99:2427-33. (Pubitemid 29218239)
6. Brignole M, Gaggioli G, Menozzi C, et al. Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncope. Heart 2000;83:24-8. (Pubitemid 30307634)
7. Perennes A, Fatemi M, Borel ML, et al. Epidemiology, clinical features, and follow-up of patients with syncope and a positive adenosine triphosphate test result. J Am Coll Cardiol 2006;47:594-7. (Pubitemid 43170850)
8. Shryock JC, Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology and pharmacology. Am J Cardiol 1997;79:2-10. (Pubitemid 27305162)
9. Saadjian A, Lévy S, Franceschi F, et al. Role of endogenous adenosine as a modulator of syncope induced during tilt testing. Circulation 2002;106:569-74. (Pubitemid 34827706)
10. 2Areceptors in patients with spontaneous and head-up-tilt-induced syncope. Heart Rhythm 2007;4:870-6.
11. 2A receptor gene polymorphism. Eur Heart J 2009;30:1510-15.
12. Brignole M, Gaggioli G, Menozzi C, et al. Adenosine-induced atrioventricular block in patients with unexplained syncope: the diagnostic value of ATP testing. Circulation 1997;96:3921-7.
13. Guieu R, Sampieri F, Bechis G, et al. Development of an HPLC diode array detector method for the determination of human plasma adenosine concentrations. J Liq Chrom 1999;22:1829-41.
14. By Y, Durand-Gorde JM, Condo J, et al. Production of an agonist-like monoclonal antibody to the human A2A receptor of adenosine for clinical use. Mol Immunol 2009;46:400-5.
15. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat 2001;29:1165-88. (Pubitemid 33575263)
16. Brignole M, Menozzi C, Del Rosso A, et al. New classification of haemodynamics of vasovagal syncope: beyong the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Europace 2000;2:66-76.
17. Iwamoto T, Umemura S, Toya Y, et al. Identification of adenosine A2 receptorc-AMP system in human aortic endothelial cells. Biochem Biophys Res Commun 1994;199:905-10.
18. Mosqueda-Garcia R, Furlan R, Tank J, et al. The elusive pathophysiology of neurally mediated syncope. Circulation 2000;102:2898-906.
19. Lerman B, Belardinelli L. Cardiac electrophysiology of adenosine. Basic and clinical concepts. Circulation 1991;83:1499-507.
20. Clemo H, Belardinelli L. Effect of adenosine on atrioventricular conduction. I: Site and characterization of adenosine action in the guinea pig atrioventricular node. Circ Res 1986;59:437-46. (Pubitemid 17211723)
21. Brignole M, Sutton R, Menozzi C, et al; International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group. Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. Eur Heart J 2006;27:2232-9. (Pubitemid 44412839)
22. Brignole M, Deharo JC, De Roy L, et al. Syncope due to idiopathic paroxysmal atrioventricular block. Long term follow up of a distinct form of atrioventriculart block. J Am Coll Cardiol 2011;58:167-73.
23. Prakash ES, Madanmohan, Narayan SK, et al. Tilt table testing evaluation of presyncope and syncope: a case-series report. Indian J Physiol Pharmacol 2004;48:213-18.
24. Tahvanainen A, Koskela J, Leskinen M, et al. Reduced systemic vascular resistance in healthy volunteers with presyncopal symptoms during a nitrate-stimulated tilt-table test. Br J Clin Pharmacol 2011;71:41-51.